Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Treasury Shares (2021 - 2025)

LifeStance Health (LFST) has disclosed Treasury Shares for 5 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 94.72% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 94.72% year-over-year, with the annual reading at $1.3 million for FY2025, 94.72% down from the prior year.
  • Treasury Shares for Q4 2025 was $1.3 million at LifeStance Health, down from $2.0 million in the prior quarter.
  • The five-year high for Treasury Shares was $30.7 million in Q3 2021, with the low at $5736.0 in Q2 2023.
  • Average Treasury Shares over 5 years is $5.6 million, with a median of $2.2 million recorded in 2025.
  • The sharpest move saw Treasury Shares crashed 99.94% in 2022, then skyrocketed 52061.79% in 2024.
  • Over 5 years, Treasury Shares stood at $23501.0 in 2021, then crashed by 39.56% to $14203.0 in 2022, then soared by 38476.36% to $5.5 million in 2023, then surged by 338.09% to $24.0 million in 2024, then tumbled by 94.72% to $1.3 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.3 million, $2.0 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.